Planet 13 Holdings (PLNH) EBITDA (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly EBITDA came in at -$4.2 million in Q1 2026, up 13.45% year-on-year from -$3.7 million in Q1 2025, and up 8.61% on a QoQ basis from -$4.6 million in Q4 2025.
Planet 13 Holdings (PLNH) EBITDA (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of EBITDA data on file, last reported at -$4.2 million in Q1 2026.
- On a quarterly basis, EBITDA rose 13.45% year-over-year to -$4.2 million in Q1 2026; TTM through Mar 2026 was -$53.2 million, a 65.13% decrease from a year earlier, with the FY2025 full-year figure at -$59.3 million, down 66.93% from the prior year.
- EBITDA for Q1 2026 stood at -$4.2 million, up from -$4.6 million in the prior quarter.
- Over the last five years, EBITDA for PLNH reached as high as $146968.0 in Q2 2022 and fell as low as -$42.0 million in Q3 2023.
- Historically, EBITDA has averaged -$10.9 million across 5 years, with a median of -$4.2 million in 2026.
- Across the five-year window, EBITDA jumped 100.72% in 2022 and plunged 3963.36% in 2025, its largest moves.
- Year by year, EBITDA stood at -$38.8 million in 2022, then surged by 76.39% to -$9.2 million in 2023, then sank by 172.45% to -$25.0 million in 2024, then soared by 81.57% to -$4.6 million in 2025, then gained by 8.61% to -$4.2 million in 2026.
- Per Business Quant data, the three most recent EBITDA figures were -$4.2 million in Q1 2026, -$4.6 million in Q4 2025, and -$39.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | -4.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.21 Mn |
| Dec 31, 2025 | -4.60 Mn |
| Sep 30, 2025 | -39.39 Mn |
| Jun 30, 2025 | -4.99 Mn |
| Mar 31, 2025 | -4.86 Mn |
| Dec 31, 2024 | -24.98 Mn |
| Sep 30, 2024 | -969,393.00 |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | -1.61 Mn |
| Dec 31, 2023 | -9.17 Mn |
| Sep 30, 2023 | -42.03 Mn |
| Jun 30, 2023 | -1.52 Mn |
| Mar 31, 2023 | -2.19 Mn |
| Dec 31, 2022 | -38.84 Mn |
| Sep 30, 2022 | -2.41 Mn |
| Jun 30, 2022 | 146,968.00 |
| Mar 31, 2022 | -1.67 Mn |
| Dec 31, 2021 | 2.49 Mn |
| Sep 30, 2021 | -6.93 Mn |
| Jun 30, 2021 | -20.47 Mn |